Copy number alterations of <i>c‐MYC</i> and <i>PTEN</i> are prognostic factors for relapse after prostate cancer radiotherapyGaetano Zafarana, Robert G. Bristow, Adrian Ishkanian et al.|Cancer|2012Cited by 125
High‐resolution array CGH identifies novel regions of genomic alteration in intermediate‐risk prostate cancerAdrian Ishkanian, Robert G. Bristow, Chad A. Mallof et al.|The Prostate|2009Cited by 80
Contrasting Circulating Tumor Cells and Free Circulating DNA Responses in Men Treated for Prostate Cancer after Primary Versus Salvage RadiotherapyRadka Stoyanova, Zheng Ao, Jorge Torres-Muñoz et al.|Clinical Oncology and Research|2020Cited by 1